Cortizas Elena M, Zahn Astrid, Safavi Shiva, Reed Joseph A, Vega Francisco, Di Noia Javier M, Verdun Ramiro E
Department of Medicine, Division of Hematology-Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136.
Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada.
J Exp Med. 2016 Oct 17;213(11):2459-2472. doi: 10.1084/jem.20160635. Epub 2016 Oct 3.
Activation-induced deaminase (AID) initiates antibody gene diversification by creating G:U mismatches in the immunoglobulin loci. However, AID also deaminates nonimmunoglobulin genes, and failure to faithfully repair these off-target lesions can cause B cell lymphoma. In this study, we identify a mechanism by which processing of G:U produced by AID at the telomeres can eliminate B cells at risk of genomic instability. We show that telomeres are off-target substrates of AID and that B cell proliferation depends on protective repair by uracil-DNA glycosylase (UNG). In contrast, in the absence of UNG activity, deleterious processing by mismatch repair leads to telomere loss and defective cell proliferation. Indeed, we show that UNG deficiency reduces B cell clonal expansion in the germinal center in mice and blocks the proliferation of tumor B cells expressing AID. We propose that AID-induced damage at telomeres acts as a fail-safe mechanism to limit the tumor promoting activity of AID when it overwhelms uracil excision repair.
活化诱导的胞嘧啶脱氨酶(AID)通过在免疫球蛋白基因座中产生G:U错配来启动抗体基因多样化。然而,AID也会使非免疫球蛋白基因发生脱氨作用,而未能忠实地修复这些脱靶损伤会导致B细胞淋巴瘤。在本研究中,我们确定了一种机制,通过该机制,AID在端粒处产生的G:U的加工过程可以消除有基因组不稳定风险的B细胞。我们表明端粒是AID的脱靶底物,并且B细胞增殖依赖于尿嘧啶-DNA糖基化酶(UNG)的保护性修复。相反,在缺乏UNG活性的情况下,错配修复的有害加工会导致端粒丢失和细胞增殖缺陷。事实上,我们表明UNG缺陷会减少小鼠生发中心的B细胞克隆扩增,并阻断表达AID的肿瘤B细胞的增殖。我们提出,当AID压倒尿嘧啶切除修复时,AID诱导的端粒损伤作为一种故障安全机制来限制AID的促肿瘤活性。